japanes
enceph
viru
jev
main
pathogen
caus
sever
enceph
human
jev
belong
genu
flaviviru
also
includ
arbovirus
dengu
viru
denv
west
nile
viru
wnv
zika
viru
zikv
jev
positivesens
singlestrand
rna
viru
genom
jev
approxim
kb
length
contain
singl
open
read
frame
orf
flank
region
utr
orf
encod
long
polyprotein
cleav
three
structur
protein
capsid
c
premembran
prm
envelop
e
seven
nonstructur
protein
structur
protein
make
infecti
viral
particl
nonstructur
protein
particip
multipl
step
viral
life
cycl
includ
viral
replic
virion
assembl
immun
evas
sinc
first
record
viru
late
jev
pose
signific
threat
global
health
report
case
jev
infect
per
year
averag
mortal
rate
caus
jev
high
past
year
proport
surviv
perman
neurolog
psychiatr
sequela
approxim
epidem
area
expans
jev
affect
approxim
countri
asia
approxim
popul
live
risk
jev
infect
present
vaccin
effect
way
prevent
jev
infect
common
vaccin
includ
inactiv
mous
brainderiv
vaccin
jevax
inactiv
cellderiv
vaccin
liveattenu
vaccin
inactiv
vero
cellderiv
vaccin
chimer
attenu
vaccin
howev
approxim
case
jev
infect
occur
area
cover
jev
vaccin
program
due
failur
immun
strategi
limit
vaccin
date
clinic
approv
antivir
agent
avail
treatment
jev
infect
furthermor
random
clinic
trial
test
treatment
jev
past
year
six
agent
treatment
jev
infect
test
clinic
trial
none
found
effect
therefor
essenti
urgent
find
safe
effect
treatment
drug
repurpos
recent
becom
popular
method
drug
discoveri
drug
repurpos
provid
old
drug
includ
approv
drug
research
drug
withdrawn
drug
new
indic
explor
new
molecular
pathway
target
strategi
find
altern
agent
treatment
jev
infect
fast
safe
past
decad
tradit
method
drug
repurpos
depend
highthroughput
screen
smallmolecul
librari
consist
approv
develop
drug
howev
success
rate
highthroughput
screen
effect
repurpos
drug
drop
dramat
develop
comput
method
highthroughput
omic
data
virtual
screen
text
mine
use
drug
repurpos
one
comput
method
antivir
drug
repurpos
target
pathogen
block
lifecycl
use
crystal
structur
e
protein
strategi
structuralbas
virtual
screen
sbv
leal
et
al
identifi
compound
exhibit
mark
antivir
activ
denv
method
antivir
drug
repurpos
target
host
gene
inhibit
pathogen
infect
identifi
protein
particip
pathogen
infect
process
basi
hosttarget
drug
repurpos
approach
quan
et
al
identifi
mycobacterium
tuberculosi
mtb
infectionassoci
gene
theoret
genet
analysi
obtain
high
potenti
antimtb
drug
target
gene
therefor
possibl
rapidli
identifi
effect
therapeut
jev
infect
use
method
drug
repurpos
target
jevsuscept
gene
system
biolog
use
identifi
pathogen
mechan
complex
human
diseas
integr
genet
variat
genom
pathway
molecular
network
advent
system
biolog
provid
power
method
facilit
drug
develop
drug
repurpos
repres
algorithm
use
system
biolog
field
includ
generank
studi
appli
method
generank
identifi
gene
essenti
jev
infect
figur
addit
analyz
gene
ontolog
go
kyoto
encyclopedia
gene
genom
kegg
athway
enrich
gene
valid
result
use
inform
drugtarget
obtain
agent
potenti
treatment
effect
jev
infect
found
multipl
target
bortezomib
play
critic
role
progress
jev
infect
base
analysi
phewa
data
enceph
gene
express
data
human
microgli
cell
jev
infect
furthermor
investig
effect
bortezomib
use
jevinfect
mous
model
overal
research
provid
novel
agent
treatment
jev
infect
gene
express
data
could
reveal
relationship
gene
jev
infect
therefor
resort
gene
express
omnibu
geo
contain
gene
express
dataset
follow
jev
infect
identifi
jevsuscept
gene
dataset
includ
sampl
detect
three
time
point
h
post
jev
infect
take
gene
express
data
detect
differ
time
whole
calcul
valu
fold
chang
use
meangen
express
thu
determin
gene
upregul
downregul
jev
infect
human
microgli
cell
ordinarili
gene
whose
fold
chang
valu
least
twofold
uninfect
group
pvalu
defin
significantli
associ
jev
infect
howev
approach
may
ignor
gene
associ
jev
infect
express
significantli
alter
therefor
use
generank
algorithm
identifi
gene
associ
jev
infect
generank
algorithm
deriv
googl
search
engin
pagerank
take
advantag
biolog
network
identifi
key
gene
associ
diseas
regardless
whether
express
alter
significantli
find
gene
associ
jev
infect
rank
gene
generank
algorithm
take
absolut
valu
fold
chang
initi
import
gene
obtain
order
function
gene
particip
jev
infect
accord
result
calcul
generank
defin
top
gene
signific
gene
involv
jev
infect
process
tabl
indic
tabl
sever
gene
report
affect
process
jev
infect
exampl
express
synthetas
oa
famili
oasl
inhibit
replic
jev
cell
one
previou
studi
member
tripartitemotif
contain
trim
protein
report
neg
regul
jev
infect
inhibit
jev
replic
degrad
viral
protein
studi
result
suggest
gene
identifi
generank
algorithm
may
play
critic
role
lifecycl
jev
understand
biolog
function
gene
rank
generank
algorithm
gene
ontolog
go
enrich
analysi
conduct
use
clusterprofil
packag
r
pvalu
use
cutoff
criterion
result
show
gene
involv
differ
cellular
function
includ
immun
respons
respons
peptid
regul
dna
metabol
process
respons
viru
respons
regul
innat
immun
respons
figur
addit
investig
involv
gene
signal
transduct
pathway
use
clusterprofil
packag
shown
figur
signific
kegg
pathway
downregul
gene
enrich
includ
human
cytomegaloviru
infect
kaposi
sarcomaassoci
herpesviru
infect
proteoglycan
cancer
hand
upregul
gene
enrich
viral
infect
pathway
includ
herp
simplex
infect
influenza
kaposi
sarcomaassoci
herpesviru
human
papillomaviru
infect
nodlik
receptor
signal
pathway
result
suggest
gene
rank
generank
algorithm
involv
viral
infect
pathway
immun
responserel
pathway
identifi
approv
drug
treatment
jev
infect
collect
inform
associ
chemic
agent
target
druggen
interact
databas
dgidb
http
dgidbgenomewustledu
therapeut
target
databas
ttd
http
biddnusedusggroupcjttd
drugbank
http
wwwdrugbankca
target
top
gene
deriv
generank
calcul
obtain
agent
might
potenti
effect
treatment
jev
infect
tabl
note
among
agent
found
bortezomib
report
abil
inhibit
denv
zikv
infect
chemic
structur
shown
figur
given
denv
zikv
jev
belong
genu
flaviviru
specul
bortezomib
may
potenti
abil
treat
jev
infect
addit
bortezomib
agent
aspirin
curcumin
etanercept
minocyclin
also
found
effect
inhibit
jev
infect
tabl
furthermor
accord
research
chen
et
al
tumor
necrosi
play
key
role
jevinduc
neuron
death
inhibitor
tnf
lenalidomid
adalimumab
may
also
potenti
effect
treatment
jev
infect
consist
mechan
underli
treatment
etanercept
jev
infect
interestingli
inhibitor
also
found
studi
result
suggest
drug
identifi
target
top
gene
generank
calcul
may
effect
treatment
jev
infect
hotnet
diffusionori
subnetwork
algorithm
base
heat
diffus
kernel
algorithm
consid
heat
individu
gene
well
topolog
genegen
interact
algorithm
reduc
fals
posit
rate
identifi
subnetwork
high
biolog
relev
sensit
real
simul
data
use
find
signific
subnetwork
associ
variou
diseas
screen
gene
jev
infect
appli
algorithm
identifi
gene
may
contribut
jev
infect
accord
snptogen
map
method
map
singl
nucleotid
polymorph
snp
phenomewid
associ
studi
phewa
data
gene
identifi
potenti
gene
associ
enceph
exhibit
similar
symptom
jev
infect
recogn
geneinteract
network
relat
enceph
use
pvalu
deriv
phewa
data
algorithm
calcul
subnetwork
obtain
subnetwork
involv
gene
associ
enceph
tabl
note
four
gene
among
three
subnetwork
belong
ubiquitin
proteasom
system
up
figur
agre
result
encephalitisrel
virus
includ
jev
west
nile
viru
wnv
venezuelan
equin
enceph
viru
veev
could
util
up
promot
viral
entri
replic
releas
addit
protein
tapbp
interact
belong
antigenload
compon
import
antivir
innat
immun
respons
protein
adar
subnetwork
report
inhibit
hepat
c
viru
hcv
replic
elimin
hcv
rna
adenosin
inosin
edit
result
confirm
gene
identifi
algorithm
import
jev
infect
target
gene
identifi
algorithm
obtain
agent
might
potenti
effect
treatment
jev
infect
tabl
interestingli
found
bortezomib
among
agent
consist
agent
obtain
generank
calcul
addit
target
bortezomib
belong
ubiquitin
proteasom
system
reinforc
hypothesi
bortezomib
may
abil
treat
jev
infect
addit
bortezomib
agent
report
antivir
activ
tabl
agent
may
also
use
treatment
jev
infect
exampl
interferon
interferon
belong
interferoni
ifni
famili
antivir
activ
report
treat
hcv
middl
east
respiratori
syndrom
coronaviru
merscov
infect
caffein
report
inhibit
hcv
replic
vitro
nontox
concentr
howev
level
hcv
rna
show
chang
patient
longterm
caffein
consumpt
valu
caffein
inhibit
hcv
replic
mm
higher
dose
caffein
may
need
treat
hcv
infect
compar
regular
dose
doxorubicin
agent
broadspectrum
anticanc
activ
report
suppress
ebola
viru
ebov
replic
vitro
also
inhibit
rna
viru
induc
ifn
respons
thu
doxorubicin
may
also
use
treatment
jev
infect
biotin
b
vitamin
bind
n
protein
porcin
epidem
diarrhea
viru
pedv
inhibit
replic
pedv
vitro
sinc
biotin
wide
use
bind
compound
protein
trace
feasibl
tag
antivir
agent
biotin
improv
antivir
activ
furthermor
antibiot
amoxicillin
clavulan
also
found
result
tabl
consid
fact
jev
infect
may
also
follow
bacteri
infect
amoxicillin
clavulan
use
reliev
inflamm
may
use
treat
jevinfect
patient
amoxicillin
clavulan
interestingli
although
evid
carfilzomib
antivir
activ
target
indic
carfilzomib
bortezomib
therefor
possibl
carfilzomib
effect
bortezomib
jev
infect
treatment
evalu
find
bortezomib
potenti
abil
inhibit
jev
infect
establish
mous
model
jev
infect
fourweekold
balbc
mice
randomli
divid
four
group
pb
group
jevinfect
group
bortezomibtr
group
jevinfect
bortezomibtr
group
mice
infect
group
intraperiton
inject
pfu
jev
strain
administ
bortezomib
intraven
everi
day
first
two
day
administ
everi
two
day
figur
anticip
mice
untreat
infect
group
die
jev
infect
mortal
rate
contrast
mortal
rate
bortezomibtr
infect
group
figur
mice
bortezomib
pb
group
surviv
end
experi
indic
bortezomib
abil
protect
mice
death
caus
jev
infect
verifi
effect
bortezomib
clinic
symptom
jev
score
clinic
behavior
mice
experi
jevinfect
mice
show
differ
behavior
noninfect
mice
includ
movement
limit
frequent
blink
bodi
stiffen
hind
limb
paralysi
clinic
behavior
bortezomibtr
infect
group
allevi
compar
untreat
infect
group
figur
indic
bortezomib
treatment
prevent
jevinfect
mice
pain
mice
bortezomib
pb
group
show
alter
behavior
suggest
bortezomib
potenti
allevi
suffer
caus
jev
infect
moreov
explor
protect
bortezomib
jev
infect
brain
collect
brain
tissu
hematoxylineosin
h
e
stain
day
day
post
infect
shown
figur
mice
jevinfect
group
suffer
signific
mening
vacuolar
degener
glial
nodul
symptom
mice
bortezomibtr
group
remark
allevi
mice
without
jev
infect
show
histolog
chang
regardless
whether
mice
treat
bortezomib
mice
group
show
evid
mening
day
post
infect
result
indic
bortezomib
could
significantli
reduc
damag
brain
caus
jev
infect
result
suggest
abil
bortezomib
treatment
flaviviru
infect
confirm
crucial
role
up
lifecycl
flavivirus
howev
anticanc
agent
bortezomib
mani
side
effect
numb
erythemat
plaqu
nodul
purpur
erupt
follicul
therefor
necessari
control
dose
clinic
treatment
pay
attent
reaction
patient
take
bortezomib
present
treatment
jev
infect
mainli
depend
symptomat
therapi
support
therapi
unfortun
effect
exist
treatment
far
perfect
approxim
survivor
report
experi
seriou
sequela
although
mani
drug
found
antijev
activ
evalu
drug
mainli
focus
anim
model
cellular
level
clinic
trial
report
therefor
necessari
rapidli
identifi
effect
therapeut
jev
infect
use
drug
repurpos
method
furthermor
sinc
jev
belong
genu
denv
zikv
identifi
agent
may
provid
treatment
strategi
virus
well
identifi
function
gene
jev
infect
essenti
find
new
antivir
agent
also
understand
viru
replic
pathogenesi
studi
util
generank
algorithm
identifi
host
gene
particip
progress
jev
infect
combin
gene
express
data
proteinprotein
interact
ppi
databas
rank
jev
infectionrel
gene
could
use
target
find
new
antivir
agent
result
show
host
protein
involv
jev
infect
includ
viral
infect
pathway
immun
responserel
pathway
consist
infect
mechan
jev
afterward
found
bortezomib
might
potenti
agent
treatment
jev
infect
target
gene
addit
identifi
genet
interact
network
relat
enceph
algorithm
use
gene
target
screen
drug
also
found
bortezomib
could
use
jev
treatment
base
result
confirm
effect
bortezomib
treatment
jev
infect
mous
model
mice
treat
bortezomib
show
signific
allevi
histopatholog
symptom
clinic
symptom
reduct
mortal
caus
jev
observ
compar
mortal
untreat
jevinfect
mice
figur
result
support
applic
hosttarget
approach
new
antivir
agent
result
provid
new
insight
molecular
mechan
jev
infect
offer
novel
agent
treatment
jev
infect
studi
phewa
data
deriv
work
denni
et
al
includ
phenotypeassoci
singl
nucleotid
polymorph
snp
jev
infect
dataset
geo
access
came
geo
wwwncbinlmnihgovgeo
proteinprotein
interact
ppi
network
use
algorithm
obtain
hint
databas
http
hintyulaborg
irefindex
databas
http
irefindexorg
multinet
includ
approxim
interact
proteinprotein
interact
ppi
network
use
generank
algorithm
deriv
string
databas
version
http
stringdborg
inform
associ
chemic
agent
target
obtain
druggen
interact
databas
dgidb
http
dgidbgenomewustledu
therapeut
target
databas
ttd
http
biddnusedusggroupcjttd
drugbank
http
wwwdrugbankca
gene
rank
generank
method
base
express
valu
interact
inform
generank
algorithm
deriv
pagerank
algorithm
describ
follow
rjn
import
gene
j
n
n
iter
repres
rjn
respect
initi
import
gene
j
repres
exj
exj
defin
fold
chang
valu
work
wij
repres
relationship
gene
j
gene
ppi
network
gene
interact
gene
j
wij
otherwis
wij
degi
outdegre
gene
mean
number
gene
interact
gene
total
number
gene
ppi
network
repres
n
paramet
constant
repres
proport
ppi
network
calcul
greater
import
ppi
network
studi
set
valu
hotnet
diffusionori
subnetwork
algorithm
topologybas
method
find
signific
subnetwork
associ
diseas
origin
algorithm
use
analyz
somat
mutat
data
cancer
dataset
initi
input
algorithm
heat
vector
contain
fraction
gene
network
protein
interact
step
node
pass
heat
receiv
heat
adjac
node
also
fraction
heat
retain
process
run
equilibrium
therefor
heat
node
equilibrium
depend
initi
heat
local
topolog
network
around
node
valu
process
describ
follow
f
w
wij
j
noed
interact
otherwis
deg
number
neighbor
ie
degre
protein
interact
network
studi
use
pvalu
enceph
deriv
phewa
data
heat
score
algorithm
bortezomib
powder
purchas
selleck
chemic
houston
tx
usa
dmso
purchas
sigmaaldrich
st
loui
mo
usa
jev
strain
kindli
provid
yunfeng
song
state
key
laboratori
agricultur
microbiolog
huazhong
agricultur
univers
china
femal
balbc
mice
purchas
hubei
provinci
center
diseas
control
prevent
wuhan
china
mice
randomli
divid
four
group
pb
group
pb
n
jevinfect
group
jev
n
bortezomibtr
group
bortezomib
n
jevinfect
bortezomibtr
group
jevbortezomib
n
jevinfect
group
mice
intraperiton
inject
pfu
jev
strain
pb
pb
group
mice
intraperiton
inject
pb
bortezomibtr
vehicletr
group
mice
intraven
inject
mgkg
bortezomib
pb
dmso
peg
jev
infect
mice
treat
bortezomib
everi
day
first
two
day
treat
everi
two
day
day
day
post
infect
five
mice
group
euthan
brain
use
subsequ
h
e
stain
ten
remain
mice
monitor
daili
assess
behavior
mortal
behavior
score
perform
base
presenc
symptom
experi
approv
scientif
ethic
committe
huazhong
agricultur
univers
histolog
analysi
brain
tissu
fix
paraformaldehyd
embed
paraffin
paraffin
section
stain
hematoxylineosin
patholog
analysi
statist
analys
conduct
use
graphpad
prism
graphpad
softwar
inc
san
diego
ca
usa
cytoscap
use
visual
subnetwork
clusterprofil
r
packag
use
perform
enrich
analysi
gene
